COMMACK, N.Y., April 29 /PRNewswire-FirstCall/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.
Dr. Krieger's expertise with Avery breathing pacemakers began in 1981 while he was Chief of Neurological Surgery at the University of Medicine and Dentistry of New Jersey. Based on that initial experience, Dr. Krieger went on to pioneer the reinnervation of the diaphragm through the use of intercostal to phrenic nerve grafts. He reported the first successful use of the technique in Neurosurgery in October, 1994. As a visiting professor, Dr. Krieger has traveled extensively around the world attending grand rounds and assisting other physicians in the development of their local diaphragm pacing programs.
Dr. Krieger most recently served as Clinical Professor in the Department of Neurological Surgery at the USC Keck School of Medicine in Los Angeles. He is currently in private practice in Beverly Hills, CA. As Chief Clinical Liaison, Dr. Krieger will lecture about the indications and latest advances in diaphragm pacing, and be available for clinical discussions regarding potential candidates for the breathing pacemaker.
Linda Towler, CEO, states, "We are honored to have Dr. Krieger join our team. His experience and expertise will be an invaluable addition to the future growth of ABD."
ABOUT ABD
Avery Biomedical Devices, Inc. (ABD) is a privately-held biomedical device manufacturer located on Long Island, New York. It produces the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation. Through its affiliate, Avery Custom Devices, Inc., ABD manufactures high-quality platinum contact electrodes for research projects, clinical trials and commerci
'/>"/>
SOURCE Avery Biomedical Devices, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report2.
Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook3.
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 20094.
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease5.
Abbott Hosts Conference Call for First-Quarter Earnings6.
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter7.
Abbott to Present at Cowen Annual Health Care Conference8.
Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary9.
Abbott Completes Acquisition of Advanced Medical Optics10.
Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore11.
Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics